Tumor Mutational Burden and COVID19 – A Pathologist’s Perspective

Episode
40
Soundcloud
Share

The latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.

Guest
Marty Edelman
Dr. Marty Edelman

MD

Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
Lynette Sholl
Dr. Lynette Sholl

MD

Associate Professor of Pathology and Associate Pathologist
Brigham and Women's Hospital, Harvard Medical School
John Longshore
John W. Longshore

PhD, FACMG

Director of Molecular Pathology
Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System